当前位置: X-MOL 学术Eur. Respir. J. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Reclassifying inconclusive diagnosis for cystic fibrosis with new generation sweat test
European Respiratory Journal ( IF 16.6 ) Pub Date : 2022-08-04 , DOI: 10.1183/13993003.00209-2022
Thao Nguyen-Khoa 1, 2, 3, 4 , Aurélie Hatton 1 , David Drummond 4, 5 , Laura Aoust 4, 5 , Joël Schlatter 6 , Clémence Martin 7 , Sophie Ramel 8 , Sébastien Kiefer 9 , Elsa Gachelin 10 , Nathalie Stremler 11 , Laure Cosson 12 , Asma Gabsi 13 , Natascha Remus 14 , Myriam Benhamida 15 , Alice Hadchouel 1, 2, 4, 5 , Isabelle Fajac 2, 7 , Anne Munck 3 , Emmanuelle Girodon 1, 2, 16 , Isabelle Sermet-Gaudelus 2, 4, 5, 17
Affiliation  

The biological diagnosis of cystic fibrosis (CF) is based on a sweat chloride (Cl) concentration (SCC) ≥60 mmol·L–1 and/or the identification of two allelic CF-causing variants [1]. Diagnosis of CF can be challenging in subjects with intermediate SCC between 30 and 59 mmol·L–1 and only one CF-causing variant detected.



中文翻译:

新一代汗液试验对囊性纤维化的不确定诊断进行重新分类

囊性纤维化 (CF) 的生物学诊断基于汗液氯化物 (Cl ) 浓度 (SCC) ≥60 mmol·L –1和/或两个等位基因导致 CF 的变异的鉴定 [1]。在 30 至 59 mmol·L –1之间的中间 SCC且仅检测到一种导致 CF 的变异的受试者中,CF 的诊断可能具有挑战性。

更新日期:2022-08-04
down
wechat
bug